3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
1
Depression
1
Interventions
Therapeutics
21
Psychiatric Rehabilitation
20
Surveys and Questionnaires
7
Early Intervention, Educational
6
Counseling
6
Yoga
5
Psychosocial Intervention
5
Cognitive Behavioral Therapy
5
Behavior Therapy
5
Mindfulness
4
Ketamine
4
Exercise
4
Escitalopram
4
Acupuncture Therapy
4
Saline Solution
3
Psilocybin
3
Mindfulness-Based Stress Reduction
3
Mindfulness-Based Cognitive Therapy
3
Methods
3
Exercise Therapy
3
Control Groups
3
Citalopram
3
Chemotherapy, Adjuvant
3
Sugars
2
Sertraline
2
Palliative Care
2
Observation
2
Niacin
2
Mental Status and Dementia Tests
2
Interviews as Topic
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Depression
×
Milnacipran
×
Clear all
NCT02783430
2025-12-16
KETAPAL
University Hospital, Lille
Phase 2/3
Completed
42 enrolled